The indirect risk is the same as with any GLP-1: nausea and vomiting, especially during dose increases, can cause you to lose a pill before its absorbed
Given that weight regain after stopping GLP-1 medication is well documented, it is reasonable to ask whether reduced drinking also reverses on discontinuation
For a more focused comparison of the first two compounds, see: Semaglutide vs Tirzepatide: What's the Difference
Weight management can begin in the postpartum period, even amid the demands of early parenthood, as long as recovery is on track
While Medicare Part D plans can cover drugs like Wegovy for patients who have obesity-related conditions like diabetes or to cut cardiovascular risks among patients who are obese (Cubanski and Neuman, 2024), a broader debate is evolving about whether public and private insurers should cover these medications to reduce obesity even if patients are not yet suffering any medical conditions associated with excess weight (Wreschnig, 2024, Ward et al., 2023, Hernandez et al., 2023)